Tender detail
Clinical trial management services for the COMBOSEQ phase III study
Summary
Fondazione IRCCS Istituto Nazionale dei Tumori is procuring contract research organization services to manage the multicentre randomized COMBOSEQ phase III clinical trial on treatment sequencing for metastatic renal cell carcinoma. The estimated contract value is €2,024,000. The notice provides for a post-award accession clause of up to 300% for consortium entities, including the foundation.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.